Teratoma formation was observed at 6 weeks post-injection; we observed that METTL1-KD-derived teratomas had a significantly increased volume and weight compared to control teratomas (Fig. 5a, b; Fig. S5b). This evidence concerns the gene METTL1 and teratoma.